56 results
8-K
EX-99.1
LIANY
LianBio
13 Nov 23
LianBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:17pm
in the first half of 2024.
Third Quarter 2023 Financial Results
Research & Development Expenses
Research and development expenses were $9.0 million … ) (Unaudited)
Three Months Ended September 30,
Nine Months Ended September 30,
Operating expenses:
Research and development
General and administrative
Total
8-K
EX-99.2
LIANY
LianBio
30 Oct 23
LianBio Announces Topline Results from Phase 3 LIBRA Trial of
4:16pm
share and per share amounts)
Historical
Pro Forma Adjustments
Pro Forma
Operating expenses:
Research and development
General and administrative …
Pro Forma Adjustments
Pro Forma
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from
8-K
EX-99.1
LIANY
LianBio
14 Aug 23
LianBio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:11pm
tumors in the first half of 2024.
Second Quarter 2023 Financial Results
Research & Development Expenses
Research and development expenses were $9.5 … 30,
Six Months Ended June 30,
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
CORRESP
ayyy1v1ga
20 Jul 23
Correspondence with SEC
12:00am
UPLOAD
cmjo3yp9
10 Jul 23
Letter from SEC
12:00am
8-K
EX-99.1
f3zjmr43o
11 May 23
LianBio Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:23pm
8-K
EX-99.1
4x096i vq2zp
19 Dec 22
Entry into a Material Definitive Agreement
7:04am
S-3/A
rp99w0 y3tbsqagu
9 Dec 22
Shelf registration (amended)
4:32pm
S-3
l1bjoz15f 013j
10 Nov 22
Shelf registration
5:26pm
8-K
EX-99.1
41ew qtnp
10 Nov 22
LianBio Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:16pm
8-K
EX-99.1
gd8 nritsn2
11 Aug 22
LianBio Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:30pm
8-K
EX-99.1
yofevvn30j1yqfqpcl6
12 May 22
LianBio Reports First Quarter 2022 Financial Results and Provides Corporate Update
9:15am
10-K
6lmo6d4si6
31 Mar 22
Annual report
8:55am